Clinical trial
The Effect of Naloxegol on Refractory Constipation in the Intensive Care Unit
NCT02705378 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Naloxegol on Refractory Constipation in the Intensive Care Unit
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- May 31, 2017
- Completion date
- December 31, 2019
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.